Identification and Biological Validation of a Chemokine/Chemokine Receptor-Based Risk Model for Predicting Immunotherapeutic Response and Prognosis in Head and Neck Squamous Cell Carcinoma

Over 80% of head and neck squamous cell carcinoma (HNSCC) patients failed to respond to immunotherapy, which can likely be attributed to the tumor microenvironment (TME) remolding mediated by chemokines/chemokine receptors (C/CR). This study aimed to establish a C/CR-based risk model for better immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ye, Wang, Shimeng, Wang, Houshang, Yang, Jin, Zhou, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963044/
https://www.ncbi.nlm.nih.gov/pubmed/36834729
http://dx.doi.org/10.3390/ijms24043317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963044/
https://www.ncbi.nlm.nih.gov/pubmed/36834729
http://dx.doi.org/10.3390/ijms24043317

Ejemplares similares